Literature DB >> 1978433

Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists.

H F Helander1, M Simonsson, F Sundler, K Rutgersson, K G Helander, S Eriksson.   

Abstract

Sixty patients with duodenal or prepyloric ulcers were given omeprazole (30 or 40 mg o.m.; average period of treatment: 2.9 weeks) or histamine H2-receptor antagonists (cimetidine 400 mg b.i.d. or ranitidine 150 mg b.i.d.; average period of treatment; 3.5 weeks) for a single period ranging between 2 and 6 weeks. At the end of the treatment period fasting plasma gastrin levels were moderately increased in both groups in comparison with the pretreatment values. Endoscopic biopsies were taken from the oxyntic mucosa at the beginning and at the end of the treatment period. Light microscopy of the biopsies was aimed particularly at determining the number of endocrine cells. In addition, the mucosal thickness and the volume densities of the parietal cells, the lamina propria and the gland lumina were measured. There were no significant differences in the endocrine or parietal cell populations, between biopsies taken from the patients before and after treatment with omeprazole or histamine H2-receptor antagonists. The mucosal thickness and the densities of the lamina propria and of the gland lumina remained unaffected by the treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978433     DOI: 10.1007/bf01605781

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  11 in total

1.  Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole.

Authors:  E Solcia; G Rindi; N Havu; G Elm
Journal:  Scand J Gastroenterol Suppl       Date:  1989

2.  Stereological investigations on human gastric mucosa: I. Normal oxyntic mucosa.

Authors:  H F Helander; R Leth; L Olbe
Journal:  Anat Rec       Date:  1986-11

3.  Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole.

Authors:  S Lanzon-Miller; R E Pounder; M R Hamilton; S Ball; N A Chronos; F Raymond; M Olausson; C Cederberg
Journal:  Aliment Pharmacol Ther       Date:  1987-06       Impact factor: 8.171

4.  Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels.

Authors:  H P Festen; J C Thijs; C B Lamers; J M Jansen; G Pals; R R Frants; J Défize; S G Meuwissen
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

5.  Endocrine cells of the gastric mucosa.

Authors:  E Solcia; C Capella; G Vassallo; R Buffa
Journal:  Int Rev Cytol       Date:  1975

6.  Endocrine cells in the human oxyntic mucosa. A histochemical study.

Authors:  M Simonsson; S Eriksson; R Håkanson; T Lind; H Lönroth; L Lundell; D T O'Connor; F Sundler
Journal:  Scand J Gastroenterol       Date:  1988-11       Impact factor: 2.423

7.  Effects of omeprazole in duodenal ulcer patients.

Authors:  A L Karvonen; O Keyriläinen; A Uusitalo; M Salaspuro; S Tarpila; K Andrén; H F Helander
Journal:  Scand J Gastroenterol       Date:  1986-05       Impact factor: 2.423

8.  Long-term omeprazole treatment in man: effects on gastric endocrine cell populations.

Authors:  R Lamberts; W Creutzfeldt; F Stöckmann; U Jacubaschke; S Maas; G Brunner
Journal:  Digestion       Date:  1988       Impact factor: 3.216

9.  Stereological changes in rat parietal cells after vagotomy and antrectomy.

Authors:  H F Helander
Journal:  Gastroenterology       Date:  1976-12       Impact factor: 22.682

10.  Enterochromaffin-like cell populations in human fundic mucosa: quantitative studies of their variations with age, sex, and plasma gastrin levels.

Authors:  D M Green; A E Bishop; G Rindi; F I Lee; M J Daly; J Domin; S R Bloom; J M Polak
Journal:  J Pathol       Date:  1989-03       Impact factor: 7.996

View more
  8 in total

1.  Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.

Authors:  D K Driman; C Wright; G Tougas; R H Riddell
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

2.  Evaluation of a proposed technique to assess unscheduled DNA synthesis and genotoxicity.

Authors:  R A Goodlad; C Y Lee; M R Alison; C E Sarraf; M A Ghatei; S R Bloom; N A Wright
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

Review 3.  Acid suppression and claims of genotoxicity. What have we learned?

Authors:  R A Goodlad
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 4.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

5.  Local cellular and immune response by antral mucosa in patients undergoing treatment for eradication of Helicobacter pylori.

Authors:  K Jaskiewicz; J A Louw; I N Marks
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

6.  Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.

Authors:  T Lehy; G Cadiot; M Mignon; P Ruszniewski; S Bonfils
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

Review 7.  Omeprazole. Gastrin and gastric endocrine cell data from clinical studies.

Authors:  R G Berlin
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

8.  Gastric epithelial cell modality and proton pump inhibitor.

Authors:  Tatsuhiro Masaoka; Hidekazu Suzuki; Toshifumi Hibi
Journal:  J Clin Biochem Nutr       Date:  2008-05       Impact factor: 3.114

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.